Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CSPC Pharmaceutical Group Limited (HK:1093)
HKEX:1093
CSPC Pharmaceutical Group (1093) Stock Price & Analysis
1 Followers
1093 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$5.09 - HK$7.26
Previous CloseHK$6.06
Volume32.41M
Average Volume (3M)45.59M
Market Cap
HK$71.75B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)11.1
Beta0.67
Next Earnings
Aug 21, 2024EPS Estimate
HK$0.15Last Dividend Ex-Date
May 31, 2024Dividend Yield4.52%
Share Statistics
EPS (TTM)0.55
Shares Outstanding11,922,719,732
10 Day Avg. Volume64,512,000
30 Day Avg. Volume45,591,155
Standard Deviation0.10
R-Squared0.18
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$10.23Price Target Upside68.75% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
CSPC Pharmaceutical Group News
PremiumCompany Announcements
CSPC Pharmaceutical’s RSV Vaccine Trials Approved
PremiumCompany Announcements
CSPC’s Novel Cancer Drug Enters U.S. Clinical Trials
PremiumCompany Announcements
CSPC Pharma’s New Anemia Drug Approved in China
PremiumCompany Announcements
CSPC Pharma’s New Cancer Drug Wins Approval
PremiumCompany Announcements
CSPC’s New Breast Cancer Drug Wins Approval
PremiumCompany Announcements
CSPC Pharma Extends Key Purchase AgreementPremiumCompany Announcements
CSPC Pharmaceutical’s CAR-T Cell Therapy Advances
PremiumCompany Announcements
CSPC Pharmaceutical Buys Shares for Award SchemeBulls Say, Bears Say
Bulls Say
Product PipelineNew products are expected to contribute meaningful revenue, with several under review and others recently approved.
Revenue GrowthStrong double-digit growth in 1Q24 revenue and attributable net profit.
Sales GrowthAccelerating growth in finished drug sales.
Bears Say
Financial PerformanceFY23 revenue saw a slight increase but attributable net profit declined, affected by price erosion of key products.
Product SalesOncology product sales weakened due to significant price cuts in centralised procurement.
Regulatory RisksDuomeisu’s potential national reimbursement pressure.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
3.74% Mutual Funds
6.51% Other Institutional Investors
89.75% Public Companies and
Individual Investors
1093 FAQ
What was CSPC Pharmaceutical Group Limited’s price range in the past 12 months?
CSPC Pharmaceutical Group Limited lowest stock price was HK$5.09 and its highest was HK$7.26 in the past 12 months.
What is CSPC Pharmaceutical Group Limited’s market cap?
Currently, no data Available
When is CSPC Pharmaceutical Group Limited’s upcoming earnings report date?
CSPC Pharmaceutical Group Limited’s upcoming earnings report date is Aug 21, 2024 which is in 35 days.
How were CSPC Pharmaceutical Group Limited’s earnings last quarter?
CSPC Pharmaceutical Group Limited released its earnings results on May 27, 2024. The company reported HK$0.146 earnings per share for the quarter, beating the consensus estimate of HK$0.127 by HK$0.019.
Is CSPC Pharmaceutical Group Limited overvalued?
According to Wall Street analysts CSPC Pharmaceutical Group Limited’s price is currently Undervalued.
Does CSPC Pharmaceutical Group Limited pay dividends?
CSPC Pharmaceutical Group Limited pays a Annually dividend of HK$0.14 which represents an annual dividend yield of 4.52%. See more information on CSPC Pharmaceutical Group Limited dividends here
What is CSPC Pharmaceutical Group Limited’s EPS estimate?
CSPC Pharmaceutical Group Limited’s EPS estimate is HK$0.15.
How many shares outstanding does CSPC Pharmaceutical Group Limited have?
CSPC Pharmaceutical Group Limited has 11,859,742,000 shares outstanding.
What happened to CSPC Pharmaceutical Group Limited’s price movement after its last earnings report?
CSPC Pharmaceutical Group Limited reported an EPS of HK$0.146 in its last earnings report, beating expectations of HK$0.127. Following the earnings report the stock price went up 7.813%.
Which hedge fund is a major shareholder of CSPC Pharmaceutical Group Limited?
Currently, no hedge funds are holding shares in HK:1093
---
CSPC Pharmaceutical Group Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-6.25%
12-Months-Change
Fundamentals
Return on Equity
18.38%
Trailing 12-Months
Asset Growth
8.61%
Trailing 12-Months
Company Description
CSPC Pharmaceutical Group Limited
CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. It operates through the following business segments: Finished Drugs, Antibiotics, Vitamin C, Caffeine and Others. The company was founded on August 21, 1997 and is headquartered in Hong Kong.
---
1093 Stock 12 Month Forecast
Average Price Target
HK$10.23
▲(68.75% Upside)
Technical Analysis
CSPC Pharmaceutical Group
―
GlaxoSmithKline
―
AstraZeneca
―
Amphastar Pharmaceuticals
―
Sanofi
―
Best Analysts Covering 1093
1 Year
1 Year Success Rate
2/5 ratings generated profit
1 Year Average Return
-6.26%
reiterated a buy rating 2 months ago
Copying Jill Wu's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -6.26% per trade.
---